On August 3rd, a new treatment developed by the TB Alliance has been approved by the European Commission for some of the most drug-resist...
Over ten million people will develop tuberculosis (TB) in the world this year; over 500,000 of these will have multidrug-resistant tuberculosis (MDR-TB). Some will receive treatment. However, we know little about the best ways of treating drug-resistant TB (DR-TB) and preventing tuberculosis in people who come in contact with DR-TB patients. TB control efforts require new evidence-based knowledge about optimal treatment regimens, prophylaxis, and regimens involving new TB drugs in order to address the growing health threats of MDR-TB and extensively drug-resistant (XDR) TB.
NEWS IN MDR-TB
Resist-TB recently hosted Dr. Dookie (Ph.D.) to speak about Individualised management of MDR and XDR-TB in South Africa using Whole G...
Mounting evidence suggests the ongoing pandemic will have significant implications for the treatment and pathology of other burdensome di...
About RESIST-TB
A movement to promote and conduct research on the treatment and prevention of drug-resistant tuberculosis (DR-TB) and provide access to effective cure and prevention of DR-TB throughout the world.
Recent RESIST-TB Products and Presentations
Upcoming webinars and presentations relating to MDR-TB trials and developments.
JOIN THE MOVEMENT!
Get the Latest News & Updates